PT Inquest is an online journal club. Hosted by Jason Tuori, Megan Graham, and Chris Juneau, the show looks at an article every week and discusses how it applies to current physical therapy practice.
…
continue reading
Content provided by Minneapolis Heart Institute Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Minneapolis Heart Institute Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Atrial Fibrillation: New Agents for Stroke Prevention
MP3•Episode home
Manage episode 155728432 series 1166503
Content provided by Minneapolis Heart Institute Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Minneapolis Heart Institute Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dr. R. Jeffrey Westcott, Medical Director at the Cardiac Cath Lab at the Swedish Heart and Vascular Institute, discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience bleeding complications and discusses the advantages of these agents versus warfarin in treating patients with non-valvular atrial fibrillation.
12 episodes
Atrial Fibrillation: New Agents for Stroke Prevention
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
MP3•Episode home
Manage episode 155728432 series 1166503
Content provided by Minneapolis Heart Institute Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Minneapolis Heart Institute Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dr. R. Jeffrey Westcott, Medical Director at the Cardiac Cath Lab at the Swedish Heart and Vascular Institute, discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience bleeding complications and discusses the advantages of these agents versus warfarin in treating patients with non-valvular atrial fibrillation.
12 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.